AV-412 Tosylate

AV-412 is a second-generation, orally bioavailable, dual-kinase inhibitor with potential anti-tumor activity. AV-412 binds and inhibits EGFR and HER2, which may result in inhibition of tumor growth and angiogenesis as well as tumor regression in EGFR/HER2-expressing tumors.
Supplier Alfa Cytology
Product # BC0375
Pricing 5.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, 500.0 mg, 1.0 g, 2.0 g, inquire
Feedback